News

The patent covers a guidewire with enhanced optical sensing capabilities, allowing it to sense locations, thickness, and structure of the arterial walls as it navigates through the body.

In this preliminary efficacy trial there appears to be no difference in overall mean visual analog scale (VAS) scores between active and placebo arms, a pharmacokinetic assessment indicates

The three physicians practicing as part of Desert Neonatal Medical Group staff the 30-bed neonatal intensive care unit (NICU) at Desert Regional Medical Center, which has annual patient

The study results support RB007’s ability to reverse the anticoagulant effect of RB006 either completely or partially, depending on the level of dosing of RB007. The study showed

The transaction includes Fiserv Health, a leading administrator of medical benefits, Avidyn Health, a care facilitation business, and the Fiserv Health Specialty Solutions businesses, which include J.W. Hutton,

Bill Hawkins, president and CEO of Medtronic, said: “The product lines and the geographic presence of these two companies are highly complementary. We expect this acquisition to help

The purpose built facility will include an expanded manufacturing plant with initial capacity sufficient to supply Bronchitol to approximately 40,000 patients per year. Pharmaxis is developing Bronchitol for

Studies 102 and 103 compare Viread to Gilead’s Hepsera (adefovir dipivoxil) among patients with HBeAg-negative (presumed pre-core mutant) chronic hepatitis B and patients with HBeAg-positive hepatitis B, respectively.

This phase II randomized, controlled trial was conducted at two centers in Egypt and is part of the company’s STEALTH C (studies to evaluate Alinia for treatment of